Valo Therapeutics(AVTX)

WAYNE, PA

Biotechnology

Focus: Oncolytic Virus, Peptide

Valo Therapeutics is a life sciences company focused on Oncolytic Virus, Peptide.

OphthalmologyOncology

Funding Stage

PUBLIC

Open Jobs

Pipeline & Clinical Trials

PeptiCRAd-1

Phase 1

Clinical Trials (1)

NCT05492682START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Phase 1

OPL-0401 Dose 1

Phase 2

Clinical Trials (1)

NCT05393284Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Phase 2

OPL-0301 Dose 1

Phase 2

Clinical Trials (1)

NCT05327855Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)

Phase 2

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 3 clinical trials

SEC Filings: 2 available

Revenue

$2M89%

R&D Spend

$14M(716%)56%

Net Income

-$32M

Cash

$7M